Add to Favorites Newsroom RSS Share
New York, NY USA

Our News on Newswise

New Study Reveals Gut Microbes May Help Protect People Having a Bone Marrow Transplant

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower...
3-Dec-2018 10:05 AM EST Add to Favorites

Memorial Sloan Kettering Researchers at ASH Annual Meeting

MSK experts in CAR-T therapy, immunotherapy, leukemia, lymphoma, blood and marrow stem cell transplantation, and more, are also available to comment on meeting news.
29-Nov-2018 3:05 PM EST Add to Favorites

Fecal Transplants Proven to Restore Health-Promoting Bacteria

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs)
8-Oct-2018 3:55 PM EDT Add to Favorites

Memorial Sloan Kettering Researchers Build a New Model of Genetically Engineered Immune Cells That May Combat Solid Tumors in the Future

Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
14-Aug-2018 12:05 PM EDT Add to Favorites


Distinguished Chemist Selected to Lead the Tri-Institutional Therapeutics Discovery Institute

Peter T. Meinke, PhD, an accomplished chemist with more than 30 years of industry and academic experience, has been selected to lead the Tri-Institutional Therapeutics Discovery Institute.
12-Jun-2018 12:05 PM EDT Add to Favorites

Genomic Markers Can Predict the Presence of Lynch Syndrome across a Broad Spectrum of Cancers

Microsatellite instability (MSI) and DNA mismatch repair (MMR) deficiencies can predict Lynch syndrome (LS) across tumor types, according to researchers from Memorial Sloan Kettering Cancer Center (MSK), who presented this retrospective data...
2-Jun-2018 8:00 AM EDT Add to Favorites


Firefighters Who Were Exposed to World Trade Center Debris Found to Have an Increased Risk for a Precancerous Condition

Researchers at Memorial Sloan Kettering (MSK) report that firefighters at the World Trade Center (WTC) scene in September 2001 were nearly twice as likely as the general population to have a multiple myeloma precursor condition called monoclonal...
2-May-2018 12:05 PM EDT Add to Favorites

Pivotal Results from Phase III Trial Show That the Combination of Ipilimumab and Nivolumab Increases Overall Survival in People with Kidney Cancer

Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus treatment with sunitinib (Sutent®) alone, according...
21-Mar-2018 11:00 AM EDT Add to Favorites

see all news

Our YouTube Videos


Memorial Sloan Kettering Cancer Center (MSK) is the world’s oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.


Jeannine Briceno
Media/Project Coordinator

Jeanne D'Agostino
Director of Media, Public Relations


Christine Hickey
Vice President, Strategic Communications & Public


Caitlin Hool
Senior Media Associate
cancer medicine


Nicole McNamara
Senior Media Associate


Avice Meehan
SVP Communications and Public Affairs

Courtney Nowak
Senior Media Associate
MSK Regional Locations, MSK Cancer Alliance


Emily ODonnell
Senior Communications Assoc.

Rebecca Williams
Media Strategist



Chat now!